These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24841157)

  • 21. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
    Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India.
    Ghosh I; Raina V; Kumar L; Sharma A; Bakhshi S; Thulkar S; Kapil A
    Med Oncol; 2012 Jun; 29(2):1354-60. PubMed ID: 21336987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.
    Seo SK; Xiao K; Huang YT; Jongwutiwes U; Chung D; Maloy M; Giralt S; Barker JN; Jakubowski AA; Papanicolaou GA
    J Infect; 2014 Oct; 69(4):341-351. PubMed ID: 24931578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.
    Ortega M; Rovira M; Almela M; Marco F; de la Bellacasa JP; Martínez JA; Carreras E; Mensa J
    Ann Hematol; 2005 Jan; 84(1):40-6. PubMed ID: 15480665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants.
    Korula A; Perumalla S; Devasia AJ; Abubacker FN; Lakshmi KM; Abraham A; Mathews V; Srivastava A; Anandan S; Veeraraghavan B; George B
    Transpl Infect Dis; 2020 Jun; 22(3):e13273. PubMed ID: 32107829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological surveillance of health care-associated infections in a pediatric hematopoietic stem cell transplantation unit in South Brazil.
    Amancio L; Ihle Garcia Giamberardino H; Ferreira E; Matucheski B; Garcia Giamberardino AL
    Transpl Infect Dis; 2021 Jun; 23(3):e13532. PubMed ID: 33249699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
    Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
    Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral status of patients submitted to autologous hematopoietic stem cell transplantation.
    Fernandes LL; Torres SR; Garnica M; de Souza Gonçalves L; Junior AS; de Vasconcellos ÁC; Cavalcanti W; Maiolino A; de Barros Torres MC
    Support Care Cancer; 2014 Jan; 22(1):15-21. PubMed ID: 23975228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
    Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
    Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
    BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.
    Raber-Durlacher JE; Laheij AM; Epstein JB; Epstein M; Geerligs GM; Wolffe GN; Blijlevens NM; Donnelly JP
    Support Care Cancer; 2013 Jun; 21(6):1621-7. PubMed ID: 23288398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease.
    Satwani P; Freedman JL; Chaudhury S; Jin Z; Levinson A; Foca MD; Krajewski J; Sahdev I; Talekar MK; Gardenswartz A; Silverman J; Hayes M; Dvorak CC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):642-647. PubMed ID: 28104513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.
    Colombier MA; Lafaurie M; de Fontbrune FS; Resche-Rigon M; Donay JL; Pons JL; Molina JM; Socie G
    Transpl Infect Dis; 2016 Aug; 18(4):504-11. PubMed ID: 27218243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bloodstream infection in patients receiving hematopoietic stem cell transplant. Seven years of experience with adults and children].
    Lipari FG; Zárate AH; García JJ; Basquíera AL; Caeiro JP
    Rev Chilena Infectol; 2017 Dec; 34(6):535-538. PubMed ID: 29488545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.
    Ren J; Lin Q; Chen W; Lin C; Zhang Y; Chen C; Chen S; Yuan X; Chen P; Luo X; Lin Y; Shen L; Guo M; Chen Q; Xiao M; Chen Y; Wu X; Zeng Y; Chen Z; Ma X; Hu J; Yang T
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):865-876. PubMed ID: 30685808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.